| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |